Mekonos
We are a Silicon Valley chip technology startup aimed primarily toward cancer immunotherapy, gene engineering and drug development.
Launch date
Employees
Market cap
-
Enterprise valuation
€91—136m (Dealroom.co estimates Nov 2021.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | - | ||
$1.0m | Seed | ||
| N/A | N/A | Seed | |
$4.6m | Early VC | ||
* | $25.0m | Series A | |
| Total Funding | €28.5m | ||
Related Content
Recent News about Mekonos
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.